BETHESDA, Md., June 3 /PRNewswire/ -- The National Foundation for Cancer
Research (NFCR) announced it has endorsed the multivitamin and dietary
supplement ONDROX(TM), manufactured by LSI America Corporation in Austin,
Texas as part of its ongoing initiative to prevent and cure cancer through
basic science. The core formulation of ONDROX(TM) was originally developed at
the M.D. Anderson Cancer Center, University of Texas. Its combination of
multiple antioxidants has been shown to be highly effective in destroying free
radicals and is the first such formulation designed on a time-release basis.
Free radicals are associated with oxidative damage to DNA, which has been
attributed to enhanced incidence rates of cancer and other immunological and
cardiovascular disorders in humans.
It has also been shown that unbalanced diets account for about one-third
of cancer risk. Micronutrients, whose main dietary sources are other than
fruits and vegetables, are likely to play a significant role in the prevention
and repair of DNA damage. Basic science research supported by NFCR has shown
how important micronutrients are in the defense against oxidative DNA damage
and the maintenance of long-term health. Several NFCR project directors have
been exploring the role of antioxidants in diet, aging and the risk of cancer.
"We believe this initiative helps to bring medical discoveries from basic
science research to the public," said NFCR president, Franklin Salisbury, Jr.
Founded in 1973, NFCR is dedicated to understanding how cancer develops
and finding a cure. With NFCR's support, scientists in all disciplines all
over the world conduct basic science cancer research at the molecular and
NFCR encourages and facilitates cooperation and the sharing of ideas and
results, enabling advances in one field to lead to progress across other
fields in cancer research. NFCR calls this cooperation the "Laboratory
Without Walls." For further information about the National Foundation for
Cancer Research, please call (800) 321-CURE or visit the web site at
LSI America Corporation is the parent holding company for LifeScience
Corporation and is engaged in the commercialization of leading edge
pharmaceutical products suitable for over the counter distribution.
ONDROX(TM) is manufactured at the facilities of Biotics Research corporation
in Houston, Texas. The Biotics plant is FDA approved and inspected, and
complies with standards exceeding those required for the production of dietary
supplements. For further information about LSI America Corporation and
ONDROX(TM), please call (888) 5-ONDROX or (800) 720-5936 and visit the web
site at www.ONDROX.com .
SOURCE The National Foundation for Cancer Research